BioNTech SE (BNTX) Total Debt (2018 - 2026)

BioNTech SE has reported Total Debt for 8 years, with the latest figure at $1.5 billion in Q4 2025.

• Quarterly Total Debt fell 37.34% year-over-year to $1.5 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 billion (down 37.34% YoY) and the FY2025 annual result came in at $1.4 billion, down 39.18% from the prior year.
• Total Debt advanced to $1.5 billion in Q4 2025 per BNTX's latest filing, from $698.4 million in the prior quarter.
• Over five years, Total Debt peaked at $2.3 billion in Q4 2024 and troughed at $157.2 million in Q2 2024.
• A 5-year average of $725.5 million and a median of $478.2 million in 2023 frame the typical range for Total Debt.
• The sharpest annual moves came in 2023 and 2024: Total Debt sank 78.19% in 2023, then soared 374.97% in 2024.
• Over 5 years, Total Debt stood at $1.6 billion in 2021, then sank by 48.42% to $807.2 million in 2022, then plunged by 39.49% to $488.5 million in 2023, then surged by 374.97% to $2.3 billion in 2024, then slumped by 37.34% to $1.5 billion in 2025.
• According to Business Quant data, Total Debt over the past three periods registered $1.5 billion, $698.4 million, and $164.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.